Healthcare provider profile · identity verified

Anna Mirzoyan, MD

Family Practice · SACRAMENTO, CA · NPI 1053463281

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	599	201
Levothyroxine Sodium	Levothyroxine Sodium	458	136
Amlodipine Besylate	Amlodipine Besylate	280	92
Atenolol	Atenolol	264	78
Metoprolol Succinate	Metoprolol Succinate	261	91
Famotidine	Famotidine	239	93
Albuterol Sulfate Hfa	Albuterol Sulfate	209	73
Lisinopril	Lisinopril	205	68
Hydrochlorothiazide	Hydrochlorothiazide	166	64
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	163	55
Prednisone	Prednisone	162	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	38
Simvastatin	Simvastatin	158	49
Furosemide	Furosemide	157	54
Metformin Hcl Er	Metformin Hcl	148	56
Rosuvastatin Calcium	Rosuvastatin Calcium	143	48
Losartan Potassium	Losartan Potassium	140	58
Fluticasone Propionate	Fluticasone Propionate	139	59
Zolpidem Tartrate	Zolpidem Tartrate	120	24
Mirtazapine	Mirtazapine	112	47
Gabapentin	Gabapentin	111	34
Tamsulosin Hcl	Tamsulosin Hcl	109	39
Meloxicam	Meloxicam	94	31
Tramadol Hcl	Tramadol Hcl	93	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	30
Ibuprofen	Ibuprofen	84	37
Omeprazole	Omeprazole	83	29
Triamcinolone Acetonide	Triamcinolone Acetonide	83	52
Potassium Chloride	Potassium Chloride	82	30
Metoprolol Tartrate	Metoprolol Tartrate	81	31
Temazepam	Temazepam	79	17
Montelukast Sodium	Montelukast Sodium	77	26
Pantoprazole Sodium	Pantoprazole Sodium	77	31
Ozempic	Semaglutide	75	13
Allopurinol	Allopurinol	72	25
Metformin Hcl	Metformin Hcl	72	25
Glipizide Er	Glipizide	71	25
Duloxetine Hcl	Duloxetine Hcl	70	24
Quetiapine Fumarate	Quetiapine Fumarate	68	22
Trazodone Hcl	Trazodone Hcl	68	31
Azithromycin	Azithromycin	67	49
Spiriva Respimat	Tiotropium Bromide	63	13
Alvesco	Ciclesonide	61	16
Cefadroxil	Cefadroxil	60	45
Alendronate Sodium	Alendronate Sodium	58	20
Alprazolam	Alprazolam	58	13
Sertraline Hcl	Sertraline Hcl	51	20
Acyclovir	Acyclovir	46	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	36
Propranolol Hcl	Propranolol Hcl	42	11
Carvedilol	Carvedilol	41	12
Citalopram Hbr	Citalopram Hydrobromide	40	14
Nystatin	Nystatin	40	18
Bupropion Xl	Bupropion Hcl	39	14
Estradiol	Estradiol	37	14
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Glipizide	Glipizide	36	16
Pradaxa	Dabigatran Etexilate Mesylate	36	14
Doxycycline Monohydrate	Doxycycline Monohydrate	35	28
Hydrocortisone	Hydrocortisone	35	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Lorazepam	Lorazepam	35	13
Wixela Inhub	Fluticasone Propion/Salmeterol	34	12
Lovastatin	Lovastatin	33	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	32	13
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	20
Eliquis	Apixaban	31	11
Spironolactone	Spironolactone	30	11
Hydroxyzine Hcl	Hydroxyzine Hcl	29	11
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Metronidazole	Metronidazole	28	18
Naproxen	Naproxen	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	12
Clobetasol Propionate	Clobetasol Propionate	27	17
Xarelto	Rivaroxaban	27	suppressed
Amoxicillin	Amoxicillin	26	19
Fenofibrate	Fenofibrate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Finasteride	Finasteride	23	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Tizanidine Hcl	Tizanidine Hcl	22	14
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	22	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Mupirocin	Mupirocin	19	15
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Creon	Lipase/Protease/Amylase	18	11
Primidone	Primidone	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	15
Levetiracetam	Levetiracetam	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	11
Ondansetron Odt	Ondansetron	14	suppressed
Topiramate	Topiramate	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Colchicine	Colchicine	12	suppressed
Digoxin	Digoxin	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Erythromycin	Erythromycin Base	12	12
Lansoprazole	Lansoprazole	12	suppressed
Asmanex Hfa	Mometasone Furoate	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error